StockData
Evotec SE logo

Evotec SE (EVO) stock

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.46−0.02 (-1.35%)

Close on Nov 18, 2026Market cap $519.11MP/E –Yield –

Evotec net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2022 it was -€175.66M, down 181.5% from the year before.

Annual net income

PeriodPeriod endValueChange
FY2022Dec 31, 2022-€175.66M-181.5%
FY2021Dec 31, 2021€215.51M+3332.8%
FY2020Dec 31, 2020€6.28M-83.5%
FY2019Dec 31, 2019€38.16M–

More Evotec figures

See a number that looks wrong?